US 12331026
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors
granted A61PA61P35/00
Quick answer
US patent 12331026 (Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors) held by NIKANG THERAPEUTICS, INC. expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- NIKANG THERAPEUTICS, INC.
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61P, A61P35/00